More serious but less common risks include acute pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal losses), and hypoglycemia when used in combination with insulin or sulfonylureas
Is GLP-1 Safe
The decision is individual and should be revisited periodically with your provider
FDA has underlined the adverse effects of DPP-IV inhibitor drugs such as Januvia, Janumet, Janumet XR, Onglyza, Kombiglyze XR, Tradjenta, Glyxambi, Jentadueto, Nesina, Kazano, and Oseni with active compounds sitagliptin, sitagliptin and metformin, sitagliptin and metformin extended release, saxagliptin, saxagliptin and metformin extended release, linagliptin, linagliptin and empagliflozin, linagliptin and metformin, alogliptin, alogliptin and metformin andalogliptin, and pioglitazone, respectively (60)
Below, were covering the top questions weve received, so you can make an informed decision either way